Impact Therapeutics Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2010.
2010 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Impact Therapeutics Limited

Impact Therapeutics Limited, a active public limited company, was established on 29 December 2010 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the trade sector, it holds CIN: U51909MH2010PLC211564. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.10 Cr and a paid-up capital of ₹15.10 Cr.

Formerly known as Miles Tradexim Private Limited, Impact Therapeutics Limited. It upholds a compliant status. Its leadership includes Ambarish Chatterjee (Director), Pooja Rajan Ambure (Director), Rakesh Grihpati Singh (Additional Director). Past directors included Sony Jena, Sriharsa Sri Kora Padhy, Ambarish Chatterjee. It holds ₹128.00 Cr open charges and ₹15.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1004, 10Th Floor, Lodha Supremus Powai, Saki Vihar Road, Opp Mtnl Office, Powai, Mumbai, Maharashtra, 400072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2010PLC211564

  • Registration Number

    211564

  • Incorporation Date

    29 December 2010

  • Authorized Capital

    ₹15.10 Cr

  • Paid-Up Capital

    ₹15.10 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.10 Cr
  • Paid Up Capital ₹ 15.10 Cr
  • Company Age 15 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 128.00 Cr
  • Satisfied Charges ₹ 15.00 Cr
  • Revenue Growth **** 94.16%
  • Profit Growth **** 847.61%
  • Ebitda **** 708.79%
  • Net Worth 56.68%
  • Total Assets **** 75.86%
Company report

Impact Therapeutics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Impact Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Impact Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Ambarish Chatterjee Director 25 Jan 2024 Current
Pooja Rajan Ambure Director 25 Jan 2024 Current
Rakesh Grihpati Singh Additional Director 15 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Additional Director 14 Mar 2020 Past
Pramod Abcsdd Director 06 May 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Impact Therapeutics.

Medec Medicare Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 94.16% increase. The company also saw a substantial improvement in profitability, with a 847.61% increase in profit. The company's net worth Soared by an impressive increase of 56.68%.

Impact Therapeutics revenue growth over time
Impact Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 94.16%
*******
*******
*******
*******
Revenue from Operations
*******
 94.13%
*******
*******
*******
*******
Total Assets
*******
 75.86%
*******
*******
*******
*******
Profit or Loss
*******
 847.61%
*******
*******
*******
*******
Net Worth
*******
 56.68%
*******
*******
*******
*******
EBITDA
*******
 708.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Impact Therapeutics?

In 2023, Impact Therapeutics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,280,000,000.00

Satisfied Charges

₹150,000,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 128.00 Cr
Latest Charge Details
Date Lender Amount Status
01 Jun 2023 Axis Bank Limited ₹20.00 Cr Open
14 Feb 2023 Axis Bank Limited ₹20.00 Cr Open
16 Feb 2022 Axis Bank Limited ₹88.00 Cr Open
11 Apr 2025 Hdfc Bank Limited ₹15.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Impact Therapeutics?

Unlock and access historical data on people associated with Impact Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Impact Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impact Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Impact Therapeutics
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 11 Apr 2025 via Charge ID 101103145 with Hdfc Bank Limited was fully satisfied on 15 Nov 2025. was documented.

  • Director Appointment

    Progress on Rakesh Grihpati Singh was appointed as a Additional Director was appointed as a Additional Director on 15 Jul 2025 & has been associated with this company since 7 months 19 days . was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 15.00 Cr with Charge ID 101103145 was registered on 11 Apr 2025. was completed.

  • Annual General Meeting

    Progress on Impact Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Impact Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Ambarish Chatterjee was appointed as a Director was appointed as a Director on 25 Jan 2024 & has been associated with this company since 2 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Impact Therapeutics Limited?

The CIN of Impact Therapeutics Limited is U51909MH2010PLC211564.

Where is Impact Therapeutics Limited headquartered?

Impact Therapeutics Limited is headquartered at 1004, 10Th Floor, Lodha Supremus Powai, Saki Vihar Road, Opp Mtnl Office, Powai, Mumbai, Maharashtra, 400072.

When was Impact Therapeutics Limited incorporated?

Impact Therapeutics Limited was incorporated on 29 December 2010.

Who are the current directors of Impact Therapeutics Limited?

The current directors of Impact Therapeutics Limited are

What is the primary industry of Impact Therapeutics Limited?

The primary industry of Impact Therapeutics Limited is Trade.

Is Impact Therapeutics Limited a listed company?

Impact Therapeutics Limited is unlisted.

What is the capital structure of Impact Therapeutics Limited?

The authorized capital of Impact Therapeutics Limited is ₹15.10 Cr, and the paid-up capital is ₹15.10 Cr.

What is the compliance status of Impact Therapeutics Limited?

The compliance status of Impact Therapeutics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available